Stratasys wins TCT healthcare award and four AMGTA sustainability honors at RAPID + TCT 2026

Stratasys received multiple industry awards at the 2026 RAPID + TCT conference, including a TCT Award in the healthcare category for the Eyelid Surgery Training Model developed with Addion GmbH. The model, built using Stratasys Digital Anatomy technology, is described as Europe’s first 3D-printed anatomical eye model for eyelid surgery training, simulating skin, muscle, and fat as an alternative to cadavers or animal models. Separately, Stratasys earned four awards at the Additive Manufacturer Green Trade Association (AMGTA) Member Summit for Environmental Management Systems, Environmental Sustainability Research, Sustainability Reporting, and Excellence in AM Sustainability. The company is a founding board member of AMGTA and said the recognition aligns with its Mindful Manufacturing framework for resource optimization.

The healthcare award is notable not for commercial scale but for demonstrating how polymer vat photopolymerization (VPP) can address a specific, high-value medical training need — replacing cadaver use with repeatable, anatomically accurate models. This fits the broader medical-dental vertical pattern where AM gains traction through application-specific qualification rather than general-purpose adoption. The AMGTA sustainability awards, meanwhile, reflect a structural shift: as AMGTA membership grows and ESG reporting becomes a procurement requirement in aerospace and defense, documented environmental management systems become a competitive differentiator rather than a marketing accessory. Stratasys, as a founding board member, is positioning its Mindful Manufacturing framework as a governance credential that could influence supplier eligibility in regulated verticals.

For Stratasys, these awards are incremental validation of two existing product lines — Digital Anatomy for medical simulation and its sustainability reporting infrastructure — rather than a market-moving event. The practical takeaway is that medical training models remain a viable, if niche, revenue stream for polymer AM, and that ESG documentation is becoming table stakes for large-enterprise AM contracts. Neither development changes Stratasys’s competitive position against HP, 3D Systems, or Bambu Lab in their respective segments, but they reinforce the company’s credibility in two areas where long-term lock-in is possible: certified medical applications and auditable sustainability claims.